Onno C. Meijer

Prof. Dr. Onno C. Meijer

Dept Medicine, div Endocrinology, Leiden University Medical Center (LUMC), The Netherlands
orcid

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 November 2017 in Gut
Verified
Journal Article
Open access
PDF file
ZLZhuang Li
Zhuang Li
CYChun-Xia Yi
Chun-Xia Yi
SKSaeed Katiraei
Saeed Katiraei
SKSander Kooijman
Sander Kooijman
EZEnchen Zhou
Enchen Zhou
YWYanan Wang
Yanan Wang
Objective Butyrate exerts metabolic benefits in mice and humans, the underlying mechanisms being still unclear. We aimed to investigate the effect of butyrate on appetite and energy expenditure, and to what extent these two components contribute to the beneficial metabolic effects of butyrate. Design Acute effects of butyrate on appetite and its method of action were investigated in mice following an intragastric gavage or intravenous injection of butyrate. To study the contribution of satiety to the metabolic benefits of butyrate, mice were fed a high-fat diet with butyrate, and an additional pair-fed group was included. Mechanistic involvement of the gut-brain neural circuit was investigated in vagotomised mice. Results Acute oral, but not intravenous, butyrate administration decreased food intake, suppressed the activity of orexigenic neurons that express neuropeptide Y in the hypothalamus, and decreased neuronal activity within the nucleus tractus solitarius and dorsal vagal complex in the brainstem. Chronic butyrate supplementation prevented diet-induced obesity, hyperinsulinaemia, hypertriglyceridaemia and hepatic steatosis, largely attributed to a reduction in food intake. Butyrate also modestly promoted fat oxidation and activated brown adipose tissue (BAT), evident from increased utilisation of plasma triglyceride-derived fatty acids. This effect was not due to the reduced food intake, but explained by an increased sympathetic outflow to BAT. Subdiaphragmatic vagotomy abolished the effects of butyrate on food intake as well as the stimulation of metabolic activity in BAT. Conclusion Butyrate acts on the gut-brain neural circuit to improve energy metabolism via reducing energy intake and enhancing fat oxidation by activating BAT.

2 March 1999 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
SCSei-Yu Chen
Sei-Yu Chen
ABAditi Bhargava
Aditi Bhargava
LMLuca Mastroberardino
Luca Mastroberardino
Onno C. MeijerOnno C. Meijer
Onno C. Meijer
JWJian Wang
Jian Wang
DPDavid Pearce
David Pearce
Sodium homeostasis in terrestrial and freshwater vertebrates is controlled by the corticosteroid hormones, principally aldosterone, which stimulate electrogenic Na + absorption in tight epithelia. Although aldosterone is known to increase apical membrane Na + permeability in target cells through changes in gene transcription, the mechanistic basis of this effect remains poorly understood. The predominant early effect of aldosterone is to increase the activity of the epithelial sodium channel (ENaC), although ENaC mRNA and protein levels do not change initially. Rather, the open probability and/or number of channels in the apical membrane are greatly increased by unknown modulators. To identify hormone-stimulated gene products that modulate ENaC activity, a subtracted cDNA library was generated from A6 cells, a stable cell line of renal distal nephron origin, and the effect of candidates on ENaC activity was tested in a coexpression assay. We report here the identification of sgk (serum and glucocorticoid-regulated kinase), a member of the serine–threonine kinase family, as an aldosterone-induced regulator of ENaC activity. sgk mRNA and protein were strongly and rapidly hormone stimulated both in A6 cells and in rat kidney. Furthermore, sgk stimulated ENaC activity approximately 7-fold when they were coexpressed in Xenopus laevis oocytes. These data suggest that sgk plays a central role in aldosterone regulation of Na + absorption and thus in the control of extracellular fluid volume, blood pressure, and sodium homeostasis.

8 January 2009 in Endocrinology
Verified
Journal Article
Closed access
EVErno Vreugdenhil
Erno Vreugdenhil
CVCarla S. L. Verissimo
Carla S. L. Verissimo
RMRob Mariman
Rob Mariman
JKJessica T. Kamphorst
Jessica T. Kamphorst
JBJoana S. Barbosa
Joana S. Barbosa
CFCarlos P. Fitzsimons
Carlos P. Fitzsimons
Glucocorticoids (GCs) exert profound effects on a variety of physiological processes, including adaptation to stress, metabolism, immunity, and neuronal development. Cellular responsiveness to GCs depends on numerous factors, including the amount of the glucocorticoid receptor (GR) protein. We tested the hypothesis that micro-RNAs (miRs), a recently discovered group of noncoding RNAs involved in mRNA translation, might control GR activity by reducing GR protein levels in neuronal tissues. We tested a panel of five miRs consisting of 124aa, 328, 524, 22, and 18. We found that miRs 18 and 124a reduced GR-mediated events in addition to decreasing GR protein levels. miR reporter assays revealed binding of miR-124a to the 3′ untranslated region of GR. In correspondence, the activation of the GR-responsive gene glucocorticoid-induced leucine zipper was strongly impaired by miR-124a and -18 overexpression. Although miR-18 is expressed widely throughout the body, expression of miR-124a is restricted to the brain. Endogenous miR-124a up-regulation during neuronal differentiation of P19 cells was associated with a decreasing amount of GR protein levels and reduced activity of luciferase reporter constructs bearing GR 3′ untranslated regions. Furthermore, we show that miR-124a expression varies over time during the stress hyporesponsive period, a neonatal period when GC signaling is modulated. Our findings demonstrate a potential role for miRs in the regulation of cell type-specific responsiveness to GCs, as may occur during critical periods of neuronal development. Ultimately, our results may provide a better understanding of the etiology of stress-related diseases as well as the efficacy of GC therapy.

1 January 2003 in Hormones and Behavior
Verified
Journal Article
Closed access
AVAlexa H Veenema
Alexa H Veenema
Onno C. MeijerOnno C. Meijer
Onno C. Meijer
RKRon de Kloet
Ron de Kloet
JKJaap M Koolhaas
Jaap M Koolhaas
BBBela G Bohus
Bela G Bohus

1 April 2018 in Frontiers in Neuroendocrinology
Verified
Journal Article
Open access
RKRon de Kloet
Ron de Kloet
Onno C. MeijerOnno C. Meijer
Onno C. Meijer
ANAlejandro F. De Nicola
Alejandro F. De Nicola
RRR.H. de Rijk
R.H. de Rijk
MJM. Joëls
M. Joëls
Bruce McEwen's discovery of receptors for corticosterone in the rat hippocampus introduced higher brain circuits in the neuroendocrinology of stress. Subsequently, these receptors were identified as mineralocorticoid receptors (MRs) that are involved in appraisal processes, choice of coping style, encoding and retrieval. The MR-mediated actions on cognition are complemented by slower actions via glucocorticoid receptors (GRs) on contextualization, rationalization and memory storage of the experience. These sequential phases in cognitive performance depend on synaptic metaplasticity that is regulated by coordinate MR- and GR activation. The receptor activation includes recruitment of coregulators and transcription factors as determinants of context-dependent specificity in steroid action; they can be modulated by genetic variation and (early) experience. Interestingly, inflammatory responses to damage seem to be governed by a similarly balanced MR:GR-mediated action as the initiating, terminating and priming mechanisms involved in stress-adaptation. We conclude with five questions challenging the MR:GR balance hypothesis.

1 April 2000 in Kidney International
Verified
Journal Article
Closed access
RKRon de Kloet
Ron de Kloet
SASaskia A.B.E. van Acker
Saskia A.B.E. van Acker
RSRosana M. Sibug
Rosana M. Sibug
MOMelly S. Oitzl
Melly S. Oitzl
Onno C. MeijerOnno C. Meijer
Onno C. Meijer
WJWybren de Jong
Wybren de Jong